These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterizing the Clinical Features and Atrophy Patterns of Young AL; Bocchetta M; Russell LL; Convery RS; Peakman G; Todd E; Cash DM; Greaves CV; van Swieten J; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Williams SCR; Alexander DC; Rohrer JD; Neurology; 2021 Aug; 97(9):e941-e952. PubMed ID: 34158384 [TBL] [Abstract][Full Text] [Related]
5. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332 [TBL] [Abstract][Full Text] [Related]
6. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation. Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551 [TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. de Silva R; Lashley T; Strand C; Shiarli AM; Shi J; Tian J; Bailey KL; Davies P; Bigio EH; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; MacKenzie J; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Holton J; Lees A; Revesz T; Mann DM Acta Neuropathol; 2006 Apr; 111(4):329-40. PubMed ID: 16552612 [TBL] [Abstract][Full Text] [Related]
8. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images. Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866 [TBL] [Abstract][Full Text] [Related]
9. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Ghetti B; Oblak AL; Boeve BF; Johnson KA; Dickerson BC; Goedert M Neuropathol Appl Neurobiol; 2015 Feb; 41(1):24-46. PubMed ID: 25556536 [TBL] [Abstract][Full Text] [Related]
10. Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN. Whitwell JL; Weigand SD; Gunter JL; Boeve BF; Rademakers R; Baker M; Knopman DS; Wszolek ZK; Petersen RC; Jack CR; Josephs KA Neurology; 2011 Jul; 77(4):393-8. PubMed ID: 21753165 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy. Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539 [TBL] [Abstract][Full Text] [Related]
12. Closing the tau loop: the missing tau mutation. McCarthy A; Lonergan R; Olszewska DA; O'Dowd S; Cummins G; Magennis B; Fallon EM; Pender N; Huey ED; Cosentino S; O'Rourke K; Kelly BD; O'Connell M; Delon I; Farrell M; Spillantini MG; Rowland LP; Fahn S; Craig P; Hutton M; Lynch T Brain; 2015 Oct; 138(Pt 10):3100-9. PubMed ID: 26297556 [TBL] [Abstract][Full Text] [Related]
13. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier. Bentham P; Staff RT; Schelter BO; Shiells H; Harrington CR; Wischik CM J Alzheimers Dis; 2021; 83(3):1017-1023. PubMed ID: 34366349 [TBL] [Abstract][Full Text] [Related]
15. MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations. Biswas MHU; Almeida S; Lopez-Gonzalez R; Mao W; Zhang Z; Karydas A; Geschwind MD; Biernat J; Mandelkow EM; Futai K; Miller BL; Gao FB Stem Cell Reports; 2016 Sep; 7(3):316-324. PubMed ID: 27594586 [TBL] [Abstract][Full Text] [Related]
16. Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques. Ishida C; Kobayashi K; Kitamura T; Ujike H; Iwasa K; Yamada M Neuropathology; 2015 Feb; 35(1):75-82. PubMed ID: 25377499 [TBL] [Abstract][Full Text] [Related]